Nventric

About Nventric

Nventric, Inc., founded in 2019 and headquartered in Arcadia, California, is a medical device company focused on developing solutions for vascular diseases. The firm operates in the surgical and medical device sector, designing, manufacturing, and marketing equipment for neurovascular, coronary, electrophysiology, and peripheral applications. Nventric's business model functions as both an Original Equipment Manufacturer (OEM) and a Contract Development, Research, and Manufacturing Organization (CDRMO), partnering with other businesses to develop and commercialize medical devices. The company provides end-to-end services from initial concept and design to volume manufacturing and regulatory support. Its research and development operations are based in the United States, with ISO 13485-certified manufacturing facilities in South Korea. Nventric's product portfolio is engineered to address complex medical conditions, with a specialty in developing devices for treating ischemic stroke. Key products under development include the Ultriva Thrombectomy System, designed for clot removal in ischemic stroke patients, and the EvoGlide distal access catheter, created for navigating complex and remote vascular areas. The company is also developing drug-eluting stents, scoring balloon catheters, and a Pulse Field Ablation (PFA) catheter that combines ablation and mapping functions for cardiac care. Nventric has actively sought funding to support its growth and global expansion. As of June 2026, the company had raised $22.8 million and was pursuing a pre-IPO funding round to accelerate its entry into the global market. The firm's stated mission is to provide healthcare professionals with high-performance tools that improve patient outcomes in interventional medicine.